Where it comes from
- Made in
- Granulosa cells of small growing follicles; Sertoli cells of the testis
- Sent out by
- Early in the follicular phase in women; steady in men, in proportion to sperm production
- Acts on
- Pituitary gonadotrophs (FSH)
What it does
In medicine
- Measured in men with infertility, where it tracks spermatogenesis and is absent in Sertoli cell-only testes 1
- An older marker of ovarian reserve, largely replaced by anti-Müllerian hormone, which varies less across the cycle
- Measured in boys with testes that cannot be felt: with anti-Müllerian hormone it tells working testicular tissue from none, and can spare a laparoscopy 2
Beyond the body’s own use
- Not a medicine and not a target. The whole interest is as a test, and the argument is over which marker to use rather than whether to give it
- Because it falls before FSH rises, it was studied as an early marker of the menopausal transition 3; it never became a test of when menopause will come, and anti-Müllerian hormone is used instead
Sources
- Pierik et al., Serum inhibin B as a marker of spermatogenesis, Journal of Clinical Endocrinology and Metabolism 1998
- Jespersen et al., Distinguishing between hidden testes and anorchia, European Journal of Endocrinology 2020
- Welt et al., Female reproductive aging is marked by decreased secretion of dimeric inhibin, Journal of Clinical Endocrinology and Metabolism 1999
This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.